By combining new preservation techniques with intelligent logistics concepts hepacult enables the user of in vitro models to save costs and reduce expenses in the process of drug development to a considerable degree.

hepacult offers following products and related services for R&D:

Hepatocytes (parenchymal cells of the human liver)

Non-parenchymal cells

"Pathocultures" (cells isolated from diseased tissue)

Tissue bank of cell components (e. g. RNA, DNA, etc.)

Recipients of these products are the pharmaceutical industry and scientific research institutes. Our customer portfolio encompasses several renowned pharmaceutical combines and biotechnological companies.